long intergenic non-protein coding RNA 2750Genealiases: []
Q-omics provides the consensus-scored LINC02750 profile across patient tissues and cancer cell-line models. LINC02750 expression is associated with patient survival in 12 of 34 cancer types, with the highest sampling consensus in HNSC. Among the 18 cancer types available for tumor–normal comparison, LINC02750 is differentially expressed in 2, with the highest sampling consensus in THCA. Additionally, LINC02750 RNA expression shows 10,992 significant gene co-expression associations, with the highest sampling consensus in TGCT. Together, these results highlight HNSC, THCA, and TGCT as cancer lineages where LINC02750 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LINC02750 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LINC02750 survival associations across molecular data types. LINC02750 RNA expression shows survival associations in the most cancer types (12). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LINC02750 RNA expression–survival associations across cancer types. High LINC02750 expression shows unfavorable associations in KICH, ACC, CHOL, UCS and LUSC, but favorable associations in HNSC. The HNSC Kaplan–Meier curve shows clear separation, with the low-expression group declining faster, consistent with the favorable association (log-rank p = .003). Together, the overview and detailed table identify HNSC as the clearest survival context for LINC02750 RNA expression.
This table summarizes LINC02750 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 2. The strongest signals are observed in THCA for RNA.
This table ranks reproducible tumor–normal expression differences for LINC02750. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LINC02750 shows lower tumor expression in THCA and higher tumor expression in LIHC. The THCA box plot shows higher LINC02750 RNA expression in normal versus tumor tissue (log2 FC = −0.017, t-test p = .016).
This table shows molecular features associated with LINC02750 in patient tissues and cancer cell lines. In patient samples, LINC02750 shows the broadest associations at the RNA and protein expression levels, with TGCT recurring as the lineage with the largest associated feature set.
